MGNX stock news · MacroGenics

Stories about MacroGenics (MGNX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for MGNX

Follow MacroGenics (MGNX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Nov 13, 2026, 9:13 AM ET · Market
MacroGenics announced it made $18.7 million in sales last quarter, down from $53.0 million a year earlier.
Neutral
MacroGenics' revenue fell to $18.7 million from $53.0 million as milestone income declined. Cash is expected to support operations through 2028, and MGC028 progress leaves no clear change in outlook.
Nov 13, 2026, 8:05 AM ET · Market
MacroGenics Receives $24.5 Million Milestone Payment from Sanofi
Good or bad for MGNX?
Oct 23, 2026, 1:24 PM ET · Market
12 health care companies are seeing big changes in their stock prices today.
Neutral
Macrogenics’ share price fell about 34% during Friday’s session, but the article gives no business reason for the drop. It adds no new information about the company’s outlook.